Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research

June 20, 2024

https://www.globenewswire.com/news-release/2024/06/20/2901624/0/en/Bionano-Announces-Software-Marketing-Agreement-with-Revvity-for-Newborn-Sequencing-Research.html

SAN DIEGO, June 20, 2024 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq:BNGO), today announced that it has entered into a software marketing agreement with Revvity, Inc. (NYSE:RVTY) under which Revvity will market and commercialize Bionano’s VIA™ software as part their newborn sequencing research workflow. VIA is expected to enhance the comprehensive reporting capabilities of Revvity’s sequencing solution by adding an assessment of CNVs to its NGS workflow and streamlining the workflow’s interpretation capabilities.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.